Abstract
Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Current Cancer Therapy Reviews
Title: The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Volume: 7 Issue: 4
Author(s): Alan M. Nieder, Jeetu Nebhnani and Fernando J. Bianco
Affiliation:
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Abstract: Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Export Options
About this article
Cite this article as:
M. Nieder Alan, Nebhnani Jeetu and J. Bianco Fernando, The Optimal Diagnosis of Urothelial Carcinoma of the Bladder, Current Cancer Therapy Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339411797642641
DOI https://dx.doi.org/10.2174/157339411797642641 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Statins-Mediated Inhibition of Rho GTPases as a Potential Tool in Anti-Tumor Therapy
Mini-Reviews in Medicinal Chemistry Quinones Derived from Plant Secondary Metabolites as Anti-cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Exfoliated Epithelial Cells: A Non-Invasive way to Evaluate the Physiological State of Gastrointestinal Epithelium
Recent Patents on Biomedical Engineering (Discontinued) Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery Discussion on the Structural Modification and Anti-tumor Activity of Flavonoids
Current Topics in Medicinal Chemistry Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Quantization of Angiogenesis and Image Analysis
Current Angiogenesis (Discontinued) Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?
Recent Patents on Anti-Cancer Drug Discovery Probiotics and Different Efficacy, How it can be Managed?
Current Drug Therapy The Scatter Factor Signaling Pathways as Therapeutic Associated Target in Cancer Treatment
Current Medicinal Chemistry Identifying Biomarkers of Lung Cancer in the Post-Genomic Era
Current Pharmacogenomics Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
Recent Patents on Anti-Cancer Drug Discovery Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials Prodrugs in Photodynamic Anticancer Therapy
Current Pharmaceutical Design Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine